89bio Inc (NASDAQ: ETNB) kicked off on Monday, up 3.27% from the previous trading day, before settling in for the closing price of $8.26. Over the past 52 weeks, ETNB has traded in a range of $6.57-$22.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -2.97%. With a float of $88.56 million, this company’s outstanding shares have now reached $93.27 million.
The extent of productivity of a business whose workforce counts for 70 workers is very important to gauge.
89bio Inc (ETNB) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of 89bio Inc is 7.00%, while institutional ownership is 101.93%. The most recent insider transaction that took place on Apr 01 ’24, was worth 575,153. In this transaction Chief Executive Officer of this company sold 52,718 shares at a rate of $10.91, taking the stock ownership to the 459,171 shares. Before that another transaction happened on Mar 04 ’24, when Company’s Director bought 1,350,000 for $15.35, making the entire transaction worth $20,722,500. This insider now owns 12,431,584 shares in total.
89bio Inc (ETNB) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2023, the organization reported -0.54 earnings per share (EPS), lower than consensus estimate (set at -0.52) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.00% during the next five years compared to -11.24% drop over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Take a look at 89bio Inc’s (ETNB) current performance indicators. Last quarter, stock had a quick ratio of 20.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.01, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -2.58 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
The latest stats from [89bio Inc, ETNB] show that its last 5-days average volume of 0.77 million was inferior to 1.21 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 17.12%. Additionally, its Average True Range was 0.57.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 11.57%, which indicates a significant decrease from 18.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.16% in the past 14 days, which was lower than the 72.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.94, while its 200-day Moving Average is $11.83. Now, the first resistance to watch is $8.68. This is followed by the second major resistance level at $8.82. The third major resistance level sits at $8.99. If the price goes on to break the first support level at $8.37, it is likely to go to the next support level at $8.20. The third support level lies at $8.06 if the price breaches the second support level.
89bio Inc (NASDAQ: ETNB) Key Stats
The company with the Market Capitalisation of 812.23 million has total of 95,225K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -142,190 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -40,240 K.
